The Parkinson disease pain classification system: results from an international mechanism-based classification approach.


Journal

Pain
ISSN: 1872-6623
Titre abrégé: Pain
Pays: United States
ID NLM: 7508686

Informations de publication

Date de publication:
01 04 2021
Historique:
received: 25 06 2020
accepted: 05 10 2020
pubmed: 13 10 2020
medline: 20 5 2021
entrez: 12 10 2020
Statut: ppublish

Résumé

Pain is a common nonmotor symptom in patients with Parkinson disease (PD) but the correct diagnosis of the respective cause remains difficult because suitable tools are lacking, so far. We developed a framework to differentiate PD- from non-PD-related pain and classify PD-related pain into 3 groups based on validated mechanistic pain descriptors (nociceptive, neuropathic, or nociplastic), which encompass all the previously described PD pain types. Severity of PD-related pain syndromes was scored by ratings of intensity, frequency, and interference with daily living activities. The PD-Pain Classification System (PD-PCS) was compared with classic pain measures (ie, brief pain inventory and McGill pain questionnaire [MPQ], PDQ-8 quality of life score, MDS-UPDRS scores, and nonmotor symptoms). 159 nondemented PD patients (disease duration 10.2 ± 7.6 years) and 37 healthy controls were recruited in 4 centers. PD-related pain was present in 122 patients (77%), with 24 (15%) suffering one or more syndromes at the same time. PD-related nociceptive, neuropathic, or nociplastic pain was diagnosed in 87 (55%), 25 (16%), or 35 (22%), respectively. Pain unrelated to PD was present in 35 (22%) patients. Overall, PD-PCS severity score significantly correlated with pain's Brief Pain Inventory and MPQ ratings, presence of dyskinesia and motor fluctuations, PDQ-8 scores, depression, and anxiety measures. Moderate intrarater and interrater reliability was observed. The PD-PCS is a valid and reliable tool for differentiating PD-related pain from PD-unrelated pain. It detects and scores mechanistic pain subtypes in a pragmatic and treatment-oriented approach, unifying previous classifications of PD-pain.

Identifiants

pubmed: 33044395
pii: 00006396-202104000-00021
doi: 10.1097/j.pain.0000000000002107
pmc: PMC7977616
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1201-1210

Informations de copyright

Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the International Association for the Study of Pain.

Références

Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S41-6
pubmed: 26459660
J Psychosom Res. 2011 Aug;71(2):74-8
pubmed: 21767686
Mov Disord Clin Pract. 2015 Aug 09;2(4):357-364
pubmed: 30363602
Nat Rev Neurol. 2012 Apr 17;8(5):284-94
pubmed: 22508236
Curr Med Res Opin. 2019 Jun;35(6):1011-1018
pubmed: 30479161
Pain. 2019 Jan;160(1):19-27
pubmed: 30586067
Mov Disord. 2010 Jan 30;25(2):213-20
pubmed: 20063386
Mov Disord. 2004 Mar;19(3):312-8
pubmed: 15022186
Pain. 1987 Aug;30(2):191-197
pubmed: 3670870
Mov Disord. 2008 Sep 15;23(12):1689-95
pubmed: 18709675
Eur J Neurol. 2016 Nov;23(11):1673-1679
pubmed: 27435448
Pain. 2009 Jan;141(1-2):173-7
pubmed: 19100686
Neurology. 2013 Feb 26;80(9):800-9
pubmed: 23365054
MMWR Morb Mortal Wkly Rep. 2018 Sep 14;67(36):1001-1006
pubmed: 30212442
Arch Neurol. 2008 Sep;65(9):1191-4
pubmed: 18779422
Mov Disord. 2011 Oct;26(12):2220-5
pubmed: 21766333
Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Brain. 2015 Mar;138(Pt 3):664-78
pubmed: 25567321
Mov Disord. 2010;25 Suppl 1:S98-103
pubmed: 20187254
Pain. 2016 Dec;157(12):2758-2765
pubmed: 27559833
J Pain Symptom Manage. 1999 Sep;18(3):180-7
pubmed: 10517039
Arq Neuropsiquiatr. 2016 Dec;74(12):990-998
pubmed: 27991997
Mov Disord. 2016 Aug;31(8):1103-13
pubmed: 27041545
J Clin Med. 2019 Jul 28;8(8):
pubmed: 31357683
J Neurol Neurosurg Psychiatry. 2007 Oct;78(10):1140-2
pubmed: 17504881
Mov Disord. 2005 Dec;20(12):1557-63
pubmed: 16078219
J Neurol Neurosurg Psychiatry. 2006 Jul;77(7):822-5
pubmed: 16549416
J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):24-8
pubmed: 18653553
Am J Epidemiol. 2004 Oct 15;160(8):797-807
pubmed: 15466502
J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52
pubmed: 2841426
Eur J Pain. 2016 Feb;20(2):151-65
pubmed: 26147660
Mov Disord. 2008 Nov 15;23(15):2129-70
pubmed: 19025984
Pain. 2005 Mar;114(1-2):29-36
pubmed: 15733628
Psychiatry (Edgmont). 2007 Jul;4(7):28-37
pubmed: 20526405
Parkinsonism Relat Disord. 2019 Jul;64:50-53
pubmed: 31072757
Neurology. 2007 Dec 4;69(23):2162-9
pubmed: 18056580
Mov Disord. 2015 Oct;30(12):1623-31
pubmed: 26096067
Pain Med. 2020 Feb 1;21(2):232-238
pubmed: 31045213
Pain. 2016 Jul;157(7):1382-1386
pubmed: 26835783
Pain. 2012 May;153(5):1107-1113
pubmed: 22456108
Neurology. 2008 Apr 29;70(18):1630-5
pubmed: 18003941
Lancet. 1986 Jun 14;1(8494):1366-9
pubmed: 2872480
J Neurol Neurosurg Psychiatry. 2017 Dec;88(12):1060-1064
pubmed: 29018160
Mov Disord. 2007 Oct 15;22(13):1901-11
pubmed: 17674410
Parkinsonism Relat Disord. 2008;14(3):205-12
pubmed: 17900967
Curr Opin Neurol. 2004 Aug;17(4):393-8
pubmed: 15247533
Pain. 2008 Aug 31;138(2):343-353
pubmed: 18289791
Pain. 2019 Jan;160(1):69-76
pubmed: 30586073
Rev Neurol (Paris). 2007 Jan;163(1):66-71
pubmed: 17304174
Mov Disord. 1986;1(1):45-9
pubmed: 3504231
Neurology. 2014 Oct 14;83(16):1403-9
pubmed: 25217059

Auteurs

Veit Mylius (V)

Department of Neurology, Center for Neurorehabilitation, Valens, Switzerland.
Department of Neurology, Kantonsspital St, Gallen, Switzerland.
Department of Neurology, Philipps University, Marburg, Germany.

Santiago Perez Lloret (S)

Biomedical Research Center (CAECIHS-UAI), National Research Council (CONICET), and Faculty of Medicine, Pontifical Catholic University of Argentina, Buenos Aires, Argentina.

Rubens G Cury (RG)

Pain Center, LIM-62, Departamento de Neurologia da Faculdade de Medicina da Universidade de Sao Paulo, Hospital das Clínicas, Sao Paulo, Brazil.

Manoel J Teixeira (MJ)

Pain Center, LIM-62, Departamento de Neurologia da Faculdade de Medicina da Universidade de Sao Paulo, Hospital das Clínicas, Sao Paulo, Brazil.

Victor R Barbosa (VR)

Pain Center, LIM-62, Departamento de Neurologia da Faculdade de Medicina da Universidade de Sao Paulo, Hospital das Clínicas, Sao Paulo, Brazil.

Egberto R Barbosa (ER)

Pain Center, LIM-62, Departamento de Neurologia da Faculdade de Medicina da Universidade de Sao Paulo, Hospital das Clínicas, Sao Paulo, Brazil.

Larissa I Moreira (LI)

Pain Center, LIM-62, Departamento de Neurologia da Faculdade de Medicina da Universidade de Sao Paulo, Hospital das Clínicas, Sao Paulo, Brazil.

Clarice Listik (C)

Pain Center, LIM-62, Departamento de Neurologia da Faculdade de Medicina da Universidade de Sao Paulo, Hospital das Clínicas, Sao Paulo, Brazil.

Ana M Fernandes (AM)

Pain Center, LIM-62, Departamento de Neurologia da Faculdade de Medicina da Universidade de Sao Paulo, Hospital das Clínicas, Sao Paulo, Brazil.

Diogo de Lacerda Veiga (D)

Pain Center, LIM-62, Departamento de Neurologia da Faculdade de Medicina da Universidade de Sao Paulo, Hospital das Clínicas, Sao Paulo, Brazil.

Julio Barbour (J)

Pain Center, LIM-62, Departamento de Neurologia da Faculdade de Medicina da Universidade de Sao Paulo, Hospital das Clínicas, Sao Paulo, Brazil.

Nathalie Hollenstein (N)

Department of Neurology, Center for Neurorehabilitation, Valens, Switzerland.

Matthias Oechsner (M)

Parkinson Center, Center for Neurological Rehabilitation, Zihlschlacht, Switzerland.

Julia Walch (J)

Department of Neurology, Kantonsspital St, Gallen, Switzerland.

Florian Brugger (F)

Department of Neurology, Kantonsspital St, Gallen, Switzerland.

Stefan Hägele-Link (S)

Department of Neurology, Kantonsspital St, Gallen, Switzerland.

Serafin Beer (S)

Department of Neurology, Center for Neurorehabilitation, Valens, Switzerland.

Alexandra Rizos (A)

King's College Hospital, Parkinson Foundation Centre of Excellence, London, United Kingdom.

Kallol Ray Chaudhuri (KR)

King's College Hospital, Parkinson Foundation Centre of Excellence, London, United Kingdom.
King's College London, Department Basic and Clinical Neuroscience, London, United Kingdom.
The Maurice Wohl Clinical Neuroscience Institute, London, United Kingdom.

Didier Bouhassira (D)

INSERM U-987, Centre d'Evaluation et de Traitement de la Douleur, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt and Université Versailles-Saint-Quentin, France.

Jean-Pascal Lefaucheur (JP)

EA 4391, Unité de Neurophysiologie Clinique, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Faculté de Médecine de Créteil, Université Paris-Est-Créteil, France.

Lars Timmermann (L)

Department of Neurology, Philipps University, Marburg, Germany.

Roman Gonzenbach (R)

Department of Neurology, Center for Neurorehabilitation, Valens, Switzerland.

Georg Kägi (G)

Department of Neurology, Kantonsspital St, Gallen, Switzerland.

Jens Carsten Möller (JC)

Department of Neurology, Philipps University, Marburg, Germany.
Parkinson Center, Center for Neurological Rehabilitation, Zihlschlacht, Switzerland.

Daniel Ciampi de Andrade (D)

Pain Center, LIM-62, Departamento de Neurologia da Faculdade de Medicina da Universidade de Sao Paulo, Hospital das Clínicas, Sao Paulo, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH